Cytokines regulate development of human mast cells from hematopoietic progenitors

International Journal of Hematology

Volumn 75, Issue 4, 2002, Pages 350-356

  Nakahata, Tatsutoshi ^a   Toru, Hano ^b  

^a KYOTO UNIVERSITY   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Fc RI; Human; Mast cell progenitor; Mast cells; Stem cell factor

Indexed keywords

CD34 ANTIGEN; CD38 ANTIGEN; CHYMASE; CYTOKINE; HISTAMINE; HLA DR ANTIGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 6; STEM CELL FACTOR; TRYPTASE;

ARTICLE; CELL ACTIVITY; CELL CULTURE; CELL MATURATION; CELL PROLIFERATION; CROSS LINKING; GENETIC TRANSCRIPTION; HEMATOPOIETIC CELL; HISTAMINE RELEASE; HUMAN; HUMAN CELL; MAST CELL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; STEM CELL; UMBILICAL CORD BLOOD; ANIMAL; CELL DIFFERENTIATION; CULTURE TECHNIQUE; CYTOLOGY; DRUG EFFECT; HEMATOPOIETIC STEM CELL; METHODOLOGY; PHENOTYPE; PHYSIOLOGY; REVIEW;

ANIMALS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CYTOKINES; HEMATOPOIETIC STEM CELLS; HUMANS; MAST CELLS; PHENOTYPE;

EID: 1842854238     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02982123     Document Type: Article

References (92)

1. Ishizaka T, Ishizaka K. Activation of mast cells for mediator release through IgE receptors. Prog Allergy. 1984;34:188-235.
2. Ishizaka T, Conrad DH, Schulman ES, Sterk AR, Ko CG, Ishizaka K. IgE-mediated triggering signals for mediator release from human mast cells and basophils. Fed Proc. 1984;43:2840-2845.
3. Moller A, Henz BM, Grutzkau A, et al. Comparative cytokine gene expression: regulation and release by human mast cells. Immunology. 1998;93:289-295.
4. Kitamura Y, Yokoyama M, Matsuda H, Ohno T, Mori KJ. Spleen-colony forming cell as common precursor for tissue mast cells and granulocytes. Nature. 1981;291:159.
5. Nakahata T, Spicer SS, Cantey JR, Ogawa M. Clonal assay of mouse mast cell colonies in methylcellulose culture. Blood. 1982;60:352-361.
6. Furitsu T, Saito H, Dvorak AM, et al. Development of human mast cells in vitro. Pro Natl Acad Sci U S A. 1989;86:10039-10043.
7. + bone marrow progenitor cells. J Immunol. 1991;146:1410-1415.
8. Irani AA, Craig SS, Nilsson G, Ishizaka T, Schwartz LB. Characterization of human mast cells development in vitro from fetal liver cells co-cultured with murine 3T3 fibroblasts. Immunology. 1992;77:136-143.
9. Valent P, Spanblöchl E, Sperr WR, et al. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture. Blood. 1992;80:2237-2245.
10. + pluripotent progenitor cells. J Immunol. 1992;148:772-777.
11. Irani AM, Nilsson G, Miettinen U, et al. Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells. Blood. 1992;80:3009-3021.
12. Mitsui H, Furitsu T, Dvorak AM, et al. Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand. Proc Natl Acad Sci U S A. 1993;90:735-739.
13. + cord blood cells stimulated with stem cell factor and interleukin-3. Blood. 1994;84:3667-3674.
14. Nakahata T, Tsuji K, Tanaka R, et al. Synergy of stem cell factor and other cytokines in mast cell development. In: Kitamura Y, Yamamoto S, Galli SJ, Greaves MW, eds. Biological and Molecular Aspects of Mast Cell and Basophil Differentiation and Function. New York: Raven Press; 1995:13-24.
15. Yin T, Taga T, Tsang ML, Yasukawa K, Kishimoto T, Yang YC. Involvement of IL-6 signal transducer gp130 in IL-11-mediated signal transduction. J Immunol. 1993;151:2555-2561.
16. Toru H, Ra C, Nonoyama S, Suzuki K, Yata J, Nakahata T. Induction of the high-affinity IgE receptor (FcεRI) on human mast cells by IL-4. Int Immunol. 1996;8:1367-1373.
17. Toru H, Kinashi T, Ra C, Nonoyama S, Yata J, Nakahata T. IL-4 induces homotypic aggregation of human cultured mast cells by promoting LFA-1/ICAM-1 adhesion molecules. Blood. 1997;89:3296-3302.
18. Toru H, Eguchi M, Matsumoto R, Yanagida M, Yata J, Nakahata T. IL-4 promotes the development of tryptase and chymase double-positive human mast cells accompanied by cell maturation. Blood. 1998;1:187-195.
19. Kampuraj D, Saito H, Kaneko A, et al. Characterization of masT-cell-committed progenitors present in human cord blood. Blood. 1999;93:3338-3346.
20. Valent P, Bettelheim P. Cell surface structures of human basophils and mast cells: biochemical and functional characterization. Adv Immunol. 1992;52:333-423.
21. Deaglio S, Morra M, Mallone R, et al. Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member. J Immunol. 1998;160:395-402.
22. Irani AM, Schwartz LB. Mast cell heterogeneity. Clin Exp Allergy. 1989;19:143-155.
23. Irani AM, Schlechter NM, Craig SS, DeBlois G, Schwartz LB. Two types of mast cells that have distinct neutral protease compositions. Proc Natl Acad Sci U S A. 1986;83:4464-4468.
24. Schwartz LB. Monoclonal antibodies against human mast cell tryptase demonstrate shared antigenic sites on subunits of tryptase and selective localization of enzyme to mast cells. J Immunol. 1985;134:526-531.
25. Schwartz LB. Mast cells: function and contents. Curr Opin Immunol. 1994;6:91-97.
26. Craig SS, Schechter NM, Schwartz LB. Ultrastructural analysis of human T and TC mast cells identified by immunoelectron microscopy. Lab Invest. 1988;58:682-691.
27. Craig SS, Schechter NM, Schwartz LB. Ultrastructural analysis of maturing human T and TC mast cells in situ. Lab Invest. 1989;60:147-157.
28. Ishizaka T, Mitsui H, Yanagida M, Miura T, Dvorak AM. Development of human mast cells from their progenitors. Curr Opin Immunol. 1993;5:937-943.
29. Dvorak AM. Human mast cells, Ultrastructural observation of in situ, ex vivo, and in vitro sites, sources, and systems. In: Kaliner MA, Metcalfe DD, eds. The Mast Cell in Health and Disease. New York: Marcel Dekker; 1992:1-90.
30. Dvorak AM, Massey W, Warner J, Kissell S, Kagey-Sobotka A, Lichtenstein LM. IgE-mediated anaphylactic degranulation of isolated human skin mast cells. Blood. 1991;77:569-578.
31. Dvorak AM, Furitu T, Ishizaka T. Ultrastructural morphology of human mast cell progenitors in sequential cocultures of cord blood cells and fibroblasts. Int Arch Allergy Immunol. 1993;100:219-229.
32. Dvorak AM, Seder RA, Paul WE, Morgan ES, Galli SJ. Effects of interleukin-3 with or without the c-kit ligand, stem cell factor, on the survival and cytoplasmic granule formation of mouse basophils and mast cells in vitro. Am J Pathol. 1994;144:160-170.
33. v mice. J Exp Med. 1985;162:1025-1043.
34. v mice: evidence that a common precursor can give rise to both "connective tissue-type" and "mucosal" mast cells. J Immunol. 1986;136:1378-1384.
35. Gurich MF, Pear WS, Stevens RL, et al. Tissue-regulated differentiation and maturation of a v-abl-immortalized mast cell-committed progenitor. Immunity. 1995;3:175-186.
36. Levi-Schaffer F, Austen KF, Gravallese PM, Stevens RL. Coculture of interleukin 3-dependent mouse mast cells with fibroblasts results in a phenotypic change of the mast cells. Proc Natl Acad Sci U S A. 1986;83:6485-6488.
37. Tsai M, Takeishi T, Thompson H, et al. Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor. Proc Natl Acad Sci U S A. 1991;88:6382-6386.
38. Gurish MF, Ghildyal N, McNeil HP, Austen KF, Gillis S, Stevens RL. Differential expression of secretary granule proteases in mouse mast cells exposed to interleukin 3 and c-kit ligand. J Exp Med. 1992;175:1003-1012.
39. Ghildyal N, McNeil HP, Stechschulte S, et al. IL-10 induces transcription of the gene for the mouse mast cell protease-1, a serine protease preferentially expressed in mucosal mast cells of Trichinella spirallis-infected mice. J Immunol. 1992;149:2123-2129.
40. Ghildyal N, McNeil HP, Gurish MF, Austen KF, Stevens RL. Transcriptional regulation of the mucosal mast cell-specific protease gene, MMCP-2, by interleukin 10 and interleukin 3. J Biol Client. 1992;267:8473-8477.
41. Eklund KK, Ghildyal N, Austen KF, Stevens RL. Induction by IL-9 and suppression by IL-3 and IL-4 of the levels of chromosome 14-derived transcripts that encode late-expressed mouse mast cell proteases. J Immunol. 1993;151:4266-4273.
42. Friend DS, Ghildyal N, Austen KF, Gurish MF, Matsumoto R, Stevens RL. Mast cells that reside at different locations in the jejunum of mice infected with Trichinella spiralis exhibit sequential changes in their granule ultrastructure and chymase phenotype. J Cell Biol. 1996;135:279-290.
43. Schwartz LB, Irani AM, Roller K, Castells MC, Schechter M. Quantitation of histamine, tryptase, and chymase in dispersed human T and TC mast cells. J Immunol. 1987;138:2611-2615.
44. Valent P, Bevec D, Maurer D, et al. Interleukin 4 promotes expression of mast cell ICAM-1 antigen. Proc Natl Acad Sci U S A. 1991;88:3339-3342.
45. Sillaber C, Strobl H, Bevec D, et al. IL-4 regulates c-kit proto-oncogene product expression in human mast and myeloid progenitor cells. J Immunol. 1991;147:4224-4228.
46. Blank U, Ra C, Miller L, White K, Metzger H, Kinet JP. Complete structure and expression in transfected cells of high affinity IgE receptor. Nature. 1989;337:187-189.
47. Lin S, Cicala C, Scharenberg A, Kinet J-P. The atopy-associated FcεRIβ chain gene: the encoded subunit functions as an amplifier of FcεRI γ-mediated cell activation signals. Cell. 1996;85:985-995.
48. Dombrowicz D, Flamard V, Brigman KK, Koller BH, Kinet J-P. Abolition of anaphylaxis by targeted disruption of the high affinity immunoglobulin E receptor A chain gene. Cell. 1993;75:969-976.
49. Takai T, Li M, Sylvestre D, Clynes R, Ravetch J. FcR gamma chain deletion results in pleitropic effector cell defects. Cell. 1994;76:519-529.
50. Ravetch JV. Fc receptors: rubor redox. Cell. 1994;78:553-560.
51. Nilsson G, Forsberg K, Bodger MP, et al. Phenotypic characterization of stem cell factor-dependent human foetal liver-derived mast cells. Immunology. 1993;79:325-330.
52. Banks EM, Coleman JW. A comparative study of peritoneal mast cells from mutant IL-4 deficient and normal mice: evidence that IL-4 is not essential for mast cell development but enhances secretion via control of IgE binding and passive sensitization. Cytokine. 1996;8:190-196.
53. Xia H-Z, Du Z, Craig S, et al. Effect of recombinant human IL-4 on tryptase, chymase, and Fcε receptor type I expression in recombinant human stem cell factor-dependent fetal liver-derived human mast cells. J Immunol. 1997;159:2911-2921.
54. Bieber T. Fc epsilon RI on human epidermal Langerhans cells: an old receptor with new structure and functions. Int Arch Allergy Immunol. 1997;113:30-34.
55. Terada N, Konno A, Terada Y, et al. IL-4 upregulates FcεRI α-chain messenger RNA in eosinophils. J Allergy Clin Immunol. 1995;96:1161-1169.
56. Yamaguchi M, Lantz CS, Oettgen HC, et al. IgE enhances mouse mast cell FcεRI expression in vitro and in vivo: evidence for a novel amplification mechanism in IgE-dependent reactions. J Exp Med. 1997;185:663-672.
57. Hsu C, MacGlasham D Jr. IgE antibody up-regulates high affinity IgE binding on murine bone marrow derived mast cells. Immunol Lett. 1996;52:129-134.
58. Yamaguchi M, Sayama K, Yano K, et al. IgE enhances Fcε receptor 1 expression and IgE-dependent release of histamine and lipid mediators from human umbilical cord blood-derived mast cells; synergistic effect of IL-4 and IgE on human mast cell Fcε receptor 1 expression and mediator release. J Immunol. 1999;162:5455-5465.
59. Daëron M, Latour S, Malbec O, et al. The same tyrosine-based inhibition motif, in the intracytoplasmic domain of FcγRII, regulates negatively BCR-, TCR-, and FcR-dependent cell activation. Immunity. 1995;3:635-646.
60. Daëron M, Malbec O, Latour S, Arock M, Fridman WH. Regulation of high-affinity IgE receptor-mediated mast cell activation by murine low-affinity IgG receptors. J Clin Invest. 1995;95:577-585.
61. Takai T, Ono M, Hikida M, Ohmori H, Ravetch JV. Augmented humoral and anaphylactic responses in FcγRII-deficient mice. Nature. 1996;379:346-349.
62. Van den Herik-Oudijk IE, Westerdaal NAC, Henriquez NV, Capel PJA, Van de Winkel JGJ. Functional analysis of human FcγRII (CD32) isoforms expressed in B lymphocytes. J Immunol. 1994;152:574-585.
63. McNiece IK, Stewart FM, Deacon DM, et al. Detection of a human CFC with a high proliferative potential. Blood. 1989;74:609-612.
64. Nakahata T, Ogawa M. Hemopoietic colony-forming cells in umbilical cord blood with extensive capability to generate monoand multipotential hemopoietic progenitors. J Clin Invest. 1982;70:1324-1328.
65. Sutherland HJ, Eaves CJ, Eaves AC, Dragowska W, Lansdorp PM. Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro. Blood. 1989;74:1563-1570.
66. Ploemacher RE, Van der Sluijs JP, Voerman JS, Brons NH. An in vitro limiting-dilution assay of long-term repopulating hematopoietic stem cells in the mouse. Blood. 1989;74:2755-2763.
67. Larochelle A, Vormoor J, Hanenberg H, et al. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nat Med. 1996;2:1329-1337.
68. Bhatia M, Wang JC, Kapp U, Bonnet D, Dick JE. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc Natl Acad Sci U S A. 1997;94:5320-5325.
69. Gan OI, Murdoch B, Larochelle A, Dick JE. Differential maintenance of primitive human SCID-repopulating cells, clonogenic progenitors, and long-term culture-initiating cells after incubation on human bone marrow stromal cells. Blood. 1997;90:641-650.
70. Wang JC, Doedens M, Dick JE. Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay. Blood. 1997;89:3919-3924.
71. Shultz LD, Schweitzer PA, Christianson SW, et al. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol. 1995;154:180-191.
72. Xu M, Tsuji K, Mukouyama Y, et al. Stimulation of mouse and human primitive hematopoiesis by murine embryonic aorta-gonad-mesonephros-derived stromal cells. Blood. 1998;192:2032-2040.
73. Ueda T, Tsuji K, Yoshino H, et al. Expansion of human NOD/ SCID-repppulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor. J Clin Invest. 2000;105:1013-1021.
74. Ueda T, Yoshino H, Kobayashi K, et al. Hematopoietic repopulating ability of cord blood CD34(+) cells in NOD/Shi-scid mice. Stem Cells. 2000;18:204-213.
75. Yoshino H, Ueda T, Kawahata M, et al. Natural killer cell depletion by anti-asialo GM1 antiserum treatment enhances human hematopoietic stem cell engraftment in NOD/Shi-scid mice. Bone Marrow Transplant. 2000;26:1211-1216.
76. Nakahata T. Ex vivo expansion of human hematopoietic stem cells. Int J Hematol. 2001;73:6-13.
77. Tsai M, Takeishi T, Thompson H, et al. Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor. Proc Natl Acad Sci U S A. 1991;88:6382-6386.
78. Iemura A, Tsai M, Ando A, Wershil BK, Galli SJ. The c-kit ligand, stem cell factor, promotes mast cell survival by suppressing apoptosis. Am J Pathol. 1994;144:321-328.
79. Galli SJ, Tsai M, Wershil BK, et al. The effects of stem cell factor, the ligand for the c-kit receptor, on mouse and human mast cell development, survival, and function. In: Kitamura Y, Yamamoto S, Galli SJ, Greaves MW, eds. Biological and Molecular Aspects of Mast Cell and Basophil Differentiation and Function. New York: Raven Press; 1995:1-11.
80. Jacoby W, Cammarata PV, Findlay S, Pincus S. Anaphylaxis in mast cell-deficient mice. J Invest Dermatol. 1984;83:302-304.
81. v mice. Int Arch Allergy Appl Immunol. 1986;80:85-94.
82. J genotypes. Exp Cell Biol. 1987;55:63-68.
83. Takeishi T, Martin TR, Katona IM, Finkelman FD, Galli SJ. Differences in the expression of cardiopulmonary alterations associated with anti-immunoglobulin E-induced or active anaphylaxis in mast cell-deficient and normal mice. J Clin Invest. 1991;88:598-608.
84. Martin TR, Ando A, Takeishi T, Katona IM, Drazen JM, Galli SJ. Mast cells contribute to the changes in heart rate, but not hypotension or death, associated with active anaphylaxis in mice. J Immunol. 1993;151:367-376.
85. Miyajima I, Dombrowicz D, Martin TR, Ravetch JV, Kinet J-P, Galli SJ. Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and FcγRIII. Assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE- or IgG1-dependent passive anaphylaxis. J Clin Invest. 1997;99:901-914.
86. Oettgen HC, Martin TR, Wynshaw-Boris A, Deng C, Drazen JM, Leder P. Active anaphylaxis in IgE-deficient mice. Nature. 1994;370:367-370.
87. Hazenbos WLW, Gessner JE, Hofhuis FMA, et al. Impaired IgG-dependent anaphylaxis and arthus reaction in FcγRIII (CD16) deficient mice. Immunity. 1996;5:181-188.
88. Echtenacher B, Männel DN, Hültner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature. 1996;381:75-77.
89. Malaviya R, Ikeda T, Ross E, Abraham SN. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α. Nature. 1996;381:77-80.
90. Patella V, Bouvet J-P, Marone G. Protein Fv produced during viral hepatitis is a novel activator of human basophils and mast cells. J Immunol. 1993;151:5685-5698.
91. Marone G, Casolaro V, Patella V, Florio G, Triggiani M. Molecular and cellular biology of mast cells and basophils. Int Arch Allergy Immunol. 1997;114:207-217.
92. Marone G. Asthma: recent advances. Immunol Today. 1998;19:5-9.